Baricitinib (Olumiant)

February 2025 in “ Canadian Journal of Health Technologies ”

CDA-AMC

TLDR Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

This document reviews the clinical and cost-effectiveness of baricitinib (Olumiant) for treating adult patients with severe alopecia areata. The assessment aims to guide reimbursement decisions across Canada, excluding Quebec, by providing nonbinding recommendations based on patient and clinician perspectives. Baricitinib is available in 2 mg and 4 mg oral tablets.

View this study on canjhealthtechnol.ca →

Discuss this study in the Community →

Related Community Posts Join

6 / 19 results

community Olumiant active ingredient Baricitinib

in Research/Science 1 upvotes 3 years ago

The conversation is about someone inquiring if anyone has tried Olumiant or its active ingredient, Baricitinib, for hair loss, mentioning the cost and that they have ordered Baricitinib.

community I am a dermatologist with a clinical interest in alopecia. AMA

in Will treatment work for me? 3 years ago

In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.

community Olumiant alternative for Alopecia Areata?

in Treatment 1 upvotes 2 years ago

A user with alopecia areata is considering treatment options like injections or Olumiant but is concerned about cost and whether delaying treatment will lead to permanent hair loss. They are seeking alternative treatments that are more affordable for a college student.

community Covid (likely) induced alopecia areata - now 2nd round of Covid, what can I expect?

in Treatment 1 upvotes 3 years ago

After experiencing hair loss due to alopecia areata following COVID-19 vaccination and infection, the individual saw improvement with steroid treatments and Olumiant. They paused Olumiant during a second COVID-19 infection and expressed concern about potential hair loss flare-ups.

community 2 and 1/2 months, prescribed 1.25mg oral min daily

in Progress Pictures 6 upvotes 5 months ago

The user is treating alopecia areata with 1.25mg oral minoxidil daily and topical mometasone furoate, considering increasing the dose or adding finasteride, though finasteride is not typically used for this condition. A gluten-free diet is suggested, and alternatives like Olumiant are mentioned.

community Article of all potential future cures

in Treatment 25 upvotes 10 months ago

Ritlecitinib and PP405 show promise for hair regrowth. Diagnosing the cause of hair loss is crucial before treatment.

Similar Research

6 / 688 results

research Janus Kinase Inhibitors in the Treatment of Alopecia Areata

2 citations , January 2023 in “Prague Medical Report”

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

research Baseline Distribution of Eyebrow and Eyelash Loss by Severity of Scalp Hair Loss in Phase 3 Trials of Baricitinib for Alopecia Areata

September 2023 in “Journal of The American Academy of Dermatology”

The document's conclusion cannot be provided because the content is not available.